ASHRAF E SEEDHOM MD NPI 1801870100

NPI Information

  • NPI: 1801870100
  • Provider Name: ASHRAF E SEEDHOM, MD
  • Classification: Internal Medicine - 207RC0000X
  • Specialization: Cardiovascular Disease
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 7 SOUTHWOODS BLVD
    CAPITAL CARDIOLOGY ASSOCIATES, PC
    ALBANY, NY
    ZIP 12211
  • Phone: (518) 292-6000

Map and Directions

Get Directions

NPI Details

Ashraf E Seedhom, MD is a cardiovascular disease internal medicine in Albany, NY with 30 years of experience. The provider is an internist who specializes in diseases of the heart and blood vessels and manages complex cardiac conditions such as heart attacks and life-threatening, abnormal heartbeat rhythms. Ashraf E Seedhom, MD NPI is 1801870100. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

7 SOUTHWOODS BLVD
CAPITAL CARDIOLOGY ASSOCIATES, PC
ALBANY, NY
ZIP 12211-526
Phone: (518) 292-6000
Fax: (518) 292-6050

The NPI 1801870100 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
  • Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only (HCPCS:93010)
  • Injection, regadenoson, 0.1 mg (HCPCS:J2785)
  • Ultrasound of heart with color-depicted blood flow, rate, direction and valve function (HCPCS:93306)
  • Technetium tc-99m sestamibi, diagnostic, per study dose (HCPCS:A9500)
  • Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99426)
  • Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician (HCPCS:93015)
  • Evaluation of cardiac rhythm monitor system, remote up to 30 days (HCPCS:93298)
  • Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec (HCPCS:G2066)
  • Principal care management services for a single high-risk disease, each additional 30 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99427)
  • Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes (HCPCS:99458)
  • Ultrasound of heart with color-depicted blood flow, rate, direction and valve function (HCPCS:93306)
  • Nuclear medicine studies of heart muscle at rest and with stress and spect (HCPCS:78452)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Ultrasound of both sides of head and neck blood flow (HCPCS:93880)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Management using the results of remote vital sign monitoring per calendar month, first 20 minutes (HCPCS:99457)
  • Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries (HCPCS:A9555)
  • Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional (HCPCS:93228)
  • Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional (HCPCS:93229)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Natriuretic peptide (heart and blood vessel protein) level (HCPCS:83880)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Transitional care management services for problem of high complexity (HCPCS:99496)
  • Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan (HCPCS:78431)
  • Nuclear medicine study of heart muscle blood flow by pet (HCPCS:78434)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Magnesium level (HCPCS:83735)
  • Ct scan of blood vessels and grafts of heart with contrast (HCPCS:75574)
  • Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
  • Ct scan of blood vessels of chest with contrast (HCPCS:71275)
  • Troponin (protein) analysis, quantitative (HCPCS:84484)
  • Principal care management services for a single high-risk disease, first 30 minutes provided personally by qualified health care professional, per calendar month. (HCPCS:99424)
  • Ultrasound of leg arteries at rest and after exercise (HCPCS:93924)
  • Transitional care management services for problem of moderate complexity (HCPCS:99495)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Limited ultrasound scan of abdomen (HCPCS:76705)
  • Hemoglobin a1c level (HCPCS:83036)
  • Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only (HCPCS:93010)
  • Thyroxine (thyroid chemical), free (HCPCS:84439)

The enumeration date for this NPI number is 12/1/2005 and was last updated on 1/30/2015.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RC0000XInternal MedicineCardiovascular Disease233746NEW YORKYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1RB3841MEDICARE PINNEW YORK
2J400003847MEDICARE PINNEW YORK
31016945MEDICAIDVERMONT
42117592MEDICAIDMASSACHUSETTS
5P00302253OTHERNEW YORKRR MEDICARE
6I26879MEDICARE UPIN
702649796MEDICAIDNEW YORK
8RA9102MEDICARE PINNEW YORK

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.